Cargando…
A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC
Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent cancers, and PANoptosis is a distinct, inflammatory-programmed cell death regulated by the PANoptosome. The essential regulators of cancer occurrence and progression are microRNAs (miRNAs). However, the potential function of PANopt...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253790/ https://www.ncbi.nlm.nih.gov/pubmed/37298343 http://dx.doi.org/10.3390/ijms24119392 |
_version_ | 1785056490223042560 |
---|---|
author | Wang, Yanmei Zhou, Jia Zhang, Nan Zhu, Yiran Zhong, Yiming Wang, Zhuo Jin, Hongchuan Wang, Xian |
author_facet | Wang, Yanmei Zhou, Jia Zhang, Nan Zhu, Yiran Zhong, Yiming Wang, Zhuo Jin, Hongchuan Wang, Xian |
author_sort | Wang, Yanmei |
collection | PubMed |
description | Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent cancers, and PANoptosis is a distinct, inflammatory-programmed cell death regulated by the PANoptosome. The essential regulators of cancer occurrence and progression are microRNAs (miRNAs). However, the potential function of PANoptosis-related microRNAs (PRMs) in ccRCC remains obscure. This study retrieved ccRCC samples from The Cancer Genome Atlas database and three Gene Expression Omnibus datasets. PRMs were recognized based on previous reports in the scientific literature. Regression analyses were used to identify the prognosis PRMs and construct a PANoptosis-related miRNA prognostic signature based on the risk score. We discovered that high-risk patients had poorer survival prognoses and were significantly linked to high-grade and advanced-stage tumors, using a variety of R software packages and web analysis tools. Furthermore, we demonstrated that the low-risk group had significant changes in their metabolic pathways. In contrast, the high-risk group was characterized by high immune cell infiltration, immune checkpoint expression, and low half-maximum inhibition concentration (IC50) values of chemotherapeutic agents. This suggests that high-risk patients may benefit more from immunotherapy and chemotherapy. In conclusion, we constructed a PANoptosis-related microRNA signature and revealed its potential significance in clinicopathological features and tumor immunity, thereby providing new precise treatment strategies. |
format | Online Article Text |
id | pubmed-10253790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102537902023-06-10 A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC Wang, Yanmei Zhou, Jia Zhang, Nan Zhu, Yiran Zhong, Yiming Wang, Zhuo Jin, Hongchuan Wang, Xian Int J Mol Sci Article Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent cancers, and PANoptosis is a distinct, inflammatory-programmed cell death regulated by the PANoptosome. The essential regulators of cancer occurrence and progression are microRNAs (miRNAs). However, the potential function of PANoptosis-related microRNAs (PRMs) in ccRCC remains obscure. This study retrieved ccRCC samples from The Cancer Genome Atlas database and three Gene Expression Omnibus datasets. PRMs were recognized based on previous reports in the scientific literature. Regression analyses were used to identify the prognosis PRMs and construct a PANoptosis-related miRNA prognostic signature based on the risk score. We discovered that high-risk patients had poorer survival prognoses and were significantly linked to high-grade and advanced-stage tumors, using a variety of R software packages and web analysis tools. Furthermore, we demonstrated that the low-risk group had significant changes in their metabolic pathways. In contrast, the high-risk group was characterized by high immune cell infiltration, immune checkpoint expression, and low half-maximum inhibition concentration (IC50) values of chemotherapeutic agents. This suggests that high-risk patients may benefit more from immunotherapy and chemotherapy. In conclusion, we constructed a PANoptosis-related microRNA signature and revealed its potential significance in clinicopathological features and tumor immunity, thereby providing new precise treatment strategies. MDPI 2023-05-28 /pmc/articles/PMC10253790/ /pubmed/37298343 http://dx.doi.org/10.3390/ijms24119392 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wang, Yanmei Zhou, Jia Zhang, Nan Zhu, Yiran Zhong, Yiming Wang, Zhuo Jin, Hongchuan Wang, Xian A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC |
title | A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC |
title_full | A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC |
title_fullStr | A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC |
title_full_unstemmed | A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC |
title_short | A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC |
title_sort | novel defined panoptosis-related mirna signature for predicting the prognosis and immune characteristics in clear cell renal cell carcinoma: a mirna signature for the prognosis of ccrcc |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253790/ https://www.ncbi.nlm.nih.gov/pubmed/37298343 http://dx.doi.org/10.3390/ijms24119392 |
work_keys_str_mv | AT wangyanmei anoveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT zhoujia anoveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT zhangnan anoveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT zhuyiran anoveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT zhongyiming anoveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT wangzhuo anoveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT jinhongchuan anoveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT wangxian anoveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT wangyanmei noveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT zhoujia noveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT zhangnan noveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT zhuyiran noveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT zhongyiming noveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT wangzhuo noveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT jinhongchuan noveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc AT wangxian noveldefinedpanoptosisrelatedmirnasignatureforpredictingtheprognosisandimmunecharacteristicsinclearcellrenalcellcarcinomaamirnasignaturefortheprognosisofccrcc |